Information Journal Paper
APA:
Copy. (2017). Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79(-), 1215-1220. SID. https://sid.ir/paper/728457/en
Vancouver:
Copy. Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY[Internet]. 2017;79(-):1215-1220. Available from: https://sid.ir/paper/728457/en
IEEE:
Copy, “Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer,” CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 79, no. -, pp. 1215–1220, 2017, [Online]. Available: https://sid.ir/paper/728457/en